Eligible UK participants with Covid-19 symptoms can join the ivermectin trial, which is being evaluated alongside the influenza antiviral favipiravir.
Eligible UK participants with Covid-19 symptoms can join the ivermectin trial, which is being evaluated alongside the influenza antiviral favipiravir.